Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

PREGABALIN 150 MG CAPSULE

Pregabalin
$0.0514per EA
DEA Schedule CV

Strength

150 mg/1

Manufacturer

Camber Pharmaceuticals Inc.

NDC

31722061405

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

PREGABALIN

Approval Type

Generic (ANDA)

FDA Application

ANDA206912

On Market Since

10/8/2019

Price History

1W

0.0%

1M

0.0%

3M

-5.5%

6M

-4.9%

1Y

-25.9%

3Y

-30.4%

5Y

N/A

All

-31.6%

Generic Alternatives

10 alternatives • Same active ingredient

PREGABALIN 150 MG CAPSULE
Generic
69367032809•Westminster Pharmaceuticals LLC
$0.0514
PREGABALIN 150 MG CAPSULE
Generic
60687051701•American Health Packaging
$0.0514
PREGABALIN 150 MG CAPSULE
Generic
69238131409•Amneal Pharmaceuticals NY LLC
$0.0514
PREGABALIN 150 MG CAPSULE
Generic
67877046690•Ascend Laboratories, LLC
$0.0514
PREGABALIN 150 MG CAPSULE
Generic
65862076290•Aurobindo Pharma Limited
$0.0514
PREGABALIN 150 MG CAPSULE
Generic
31722061490•Camber Pharmaceuticals Inc.
$0.0514
PREGABALIN 150 MG CAPSULE
Generic
62135044790•Chartwell RX LLC
$0.0514
PREGABALIN 150 MG CAPSULE
Generic
72205001590•Novadoz Pharmaceuticals LLC
$0.0514
PREGABALIN 150 MG CAPSULE
Generic
13668036205•Torrent Pharmaceuticals Limited
$0.0514
PREGABALIN 150 MG CAPSULE
Generic
62332012390•Alembic Pharmaceuticals Inc.
$0.0514

Related Drugs

Same classification

No related drugs found.

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy